Polymeric drugs based on random copolymers with antimitotic activity.

Area of Science:

• Polymer Chemistry
• Materials Science
• Biomedical Engineering

Background:

• Development of novel polymeric drugs is crucial for targeted cancer therapy.
• Antimitotic agents are essential for inhibiting cell proliferation in cancer treatment.
• Random copolymers offer tunable properties for drug delivery applications.

Purpose of the Study:

• To synthesize and characterize random copolymers of OAGMA and EPM for potential use as polymeric drugs.
• To investigate the microstructure, physicochemical properties, and biological activity of these copolymers.
• To evaluate the thermosensitive behavior and in vitro drug release of the developed polymeric systems.

Main Methods:

• Free radical copolymerization of OAGMA and EPM at varying conversions.
• Analysis of copolymer microstructure, including reactivity ratios and sequence distribution.
• Determination of glass transition temperature and thermosensitive behavior (cloud point temperature).
• In vitro studies on glycolipid release and cytotoxicity assays on glioblastoma and fibroblast cell lines.

Main Results:

• Statistical random copolymers with random sequence distribution were successfully synthesized.
• Copolymers exhibited thermosensitive behavior with tunable cloud point temperatures.
• In vitro release studies confirmed the stability of the ester group.
• Polymeric drugs with 30-50 mol% OAGMA demonstrated significant antimitotic activity against human glioblastoma cells.
• Reduced toxicity was observed on normal human fibroblast cultures.

Conclusions:

• Random copolymers of OAGMA and EPM represent a promising platform for developing effective and selective polymeric drugs.
• The thermosensitive nature and controlled release properties enhance their potential for targeted cancer therapy.
• These polymeric drugs offer a favorable therapeutic window due to their selective toxicity against cancer cells.